Back to results
Unknown

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension

NCT04937959

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Syrentis Clinical Research

Santa Ana, California, United States

Contact

Head of Clinical Operations

07849522891s2@novoic.com
View on ClinicalTrials.gov
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension — TrialFind